Skip to content

Clinical trials

Nervous System Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Country / region: Taiwan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20161
20171
20183
20201
20222
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting6
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
GlaxoSmithKline2
National Taiwan University Hospital2
4D Molecular Therapeutics1
ALPS Biotech CO. LTD1
AbbVie1
AstraZeneca1
Intellia Therapeutics1
Medtronic1
Neuroscience Trials Australia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases16
Brain Diseases8
Central Nervous System Diseases7
Alzheimer Disease5
Neurodegenerative Diseases5
Dementia4
Mental Disorders4
Cardiovascular Diseases3
Genetic Diseases, Inborn3
Cerebrovascular Disorders2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.